Appendix B: Panel Roster and Financial Disclosures
Herpes (HSV/VZV)
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Christine Durand | Johns Hopkins University, School of Medicine | AbbVie Gilead Sciences GlaxoSmithKline |
Research Support (paid to institution) |
| Gilead Sciences | Grant Review Committee, Honorarium | ||
| John Gnann | Medical University of South Carolina | GlaxoSmithKline | Consultant |
| BioCryst | Data Safety Monitoring Board | ||
| Gary Holland | David Geffen School of Medicine at the University of California Los Angeles | None | N/A |
| Christine Johnston | University of Washington School of Medicine | Gilead Sciences AbbVie |
Consultant |
| Shannon Ross | The University of Alabama at Birmingham Marnix E. Heersink School of Medicine | None | N/A |
| Nicholas Van Wagoner* | The University of Alabama at Birmingham Marnix E. Heersink School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section OnlyPDF (31.55 KB)
- Full GuidelinePDF (5.25 MB)
- Tables OnlyPDF (947.68 KB)